Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Comprehensive investigation of cytokine- and immune-related gene variants in HBV-associated hepatocellular carcinoma patients.

Yu F, Zhang X, Tian S, Geng L, Xu W, Ma N, Wang M, Jia Y, Liu X, Ma J, Quan Y, Zhang C, Guo L, An W, Liu D.

Biosci Rep. 2017 Dec 12;37(6). pii: BSR20171263. doi: 10.1042/BSR20171263. Print 2017 Dec 22.

2.

Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.

Ji X, Zhang Q, Li B, Du Y, Yin J, Liu W, Zhang H, Cao G.

Infect Genet Evol. 2014 Dec;28:201-9. doi: 10.1016/j.meegid.2014.09.032. Epub 2014 Oct 2.

PMID:
25281206
3.

Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.

Li S, Deng Y, Chen ZP, Huang S, Liao XC, Lin LW, Li H, Peng T, Qin X, Zhao JM.

Infect Genet Evol. 2011 Dec;11(8):2083-8. doi: 10.1016/j.meegid.2011.09.025. Epub 2011 Oct 12.

PMID:
22019522
4.

Comprehensive investigating of cytokine and receptor related genes variants in patients with chronic hepatitis B virus infection.

Yu F, Ma N, Zhang X, Tian S, Geng L, Xu W, Wang M, Jia Y, Liu X, Ma J, Quan Y, Zhang C, Guo L, An W, Liu D.

Cytokine. 2018 Mar;103:10-14. doi: 10.1016/j.cyto.2017.12.017. Epub 2017 Dec 26.

PMID:
29287219
5.

Association between interleukin-21 gene polymorphisms (rs12508721) and HBV-related hepatocellular carcinoma.

Zhang QX, Li SL, Yao YQ, Li TJ.

Int J Immunogenet. 2016 Jun;43(3):151-8. doi: 10.1111/iji.12263. Epub 2016 Apr 28.

PMID:
27122304
6.

Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.

Han Y, Pu R, Han X, Zhao J, Li W, Yin J, Zhang Y, Shen Q, Xie J, Zhang Q, Jiang S, Li J, Zhang H, Wang H, Cao G.

Liver Int. 2014 May;34(5):728-36. doi: 10.1111/liv.12313. Epub 2013 Oct 1.

PMID:
24118778
7.

[Association of interleukin-12 gene polymorphism with persistence of hepatitis B virus infection and hepatocellular carcinoma].

Park JS, Cheong JY, Kang JK, Cho JH, Yu S, Shin HD, Park BL, Cho SW.

Korean J Gastroenterol. 2007 Nov;50(5):313-8. Korean.

8.

Association between polymorphisms of the APOBEC3G gene and chronic hepatitis B viral infection and hepatitis B virus-related hepatocellular carcinoma.

He XT, Xu HQ, Wang XM, He XS, Niu JQ, Gao PJ.

World J Gastroenterol. 2017 Jan 14;23(2):232-241. doi: 10.3748/wjg.v23.i2.232.

9.

-509C>T polymorphism in the TGF-beta1 gene promoter, impact on the hepatocellular carcinoma risk in Chinese patients with chronic hepatitis B virus infection.

Qi P, Chen YM, Wang H, Fang M, Ji Q, Zhao YP, Sun XJ, Liu Y, Gao CF.

Cancer Immunol Immunother. 2009 Sep;58(9):1433-40. doi: 10.1007/s00262-009-0660-4. Epub 2009 Jan 25.

PMID:
19169878
10.

Hepatitis B virus-associated hepatocellular carcinoma from India: role of viral genotype and mutations in CTNNB1 (beta-catenin) and TP53 genes.

Vivekanandan P, Torbenson M, Ramakrishna B.

J Gastrointest Cancer. 2011 Mar;42(1):20-5. doi: 10.1007/s12029-010-9222-4.

PMID:
20963515
11.

Genetic variants in IL12 influence both hepatitis B virus clearance and HBV-related hepatocellular carcinoma development in a Chinese male population.

Tan A, Gao Y, Yao Z, Su S, Jiang Y, Xie Y, Xian X, Mo Z.

Tumour Biol. 2016 May;37(5):6343-8. doi: 10.1007/s13277-015-4520-x. Epub 2015 Dec 2.

PMID:
26631030
12.

Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development.

Hu L, Zhai X, Liu J, Chu M, Pan S, Jiang J, Zhang Y, Wang H, Chen J, Shen H, Hu Z.

Hepatology. 2012 May;55(5):1426-31. doi: 10.1002/hep.24799. Epub 2012 Mar 16.

PMID:
22105689
13.

Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA.

Zhu C, Song H, Shen B, Wu L, Liu F, Liu X.

Lipids Health Dis. 2017 Jan 11;16(1):5. doi: 10.1186/s12944-016-0400-7.

14.

Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma.

Chen CC, Yang SY, Liu CJ, Lin CL, Liaw YF, Lin SM, Lee SD, Chen PJ, Chen CJ, Yu MW.

Int J Epidemiol. 2005 Dec;34(6):1310-8. Epub 2005 Sep 19.

PMID:
16172101
15.

HLA-DP polymorphisms affect the outcomes of chronic hepatitis B virus infections, possibly through interacting with viral mutations.

Zhang Q, Yin J, Zhang Y, Deng Y, Ji X, Du Y, Pu R, Han Y, Zhao J, Han X, Zhang H, Cao G.

J Virol. 2013 Nov;87(22):12176-86. doi: 10.1128/JVI.02073-13. Epub 2013 Sep 4.

16.

Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in chronic hepatitis B.

Yeung P, Wong DK, Lai CL, Fung J, Seto WK, Yuen MF.

J Infect Dis. 2011 Mar 1;203(5):646-54. doi: 10.1093/infdis/jiq096. Epub 2011 Jan 12.

17.

Hepatitis B virus genotype, mutations, human leukocyte antigen polymorphisms and their interactions in hepatocellular carcinoma: a multi-centre case-control study.

Wen J, Song C, Jiang D, Jin T, Dai J, Zhu L, An J, Liu Y, Ma S, Qin N, Liang C, Chen J, Jiang Y, Yang L, Liu J, Liu L, Geng T, Chen C, Jiang J, Chen J, Zhu F, Zhu Y, Yu L, Shen H, Zhai X, Xu J, Hu Z.

Sci Rep. 2015 Nov 16;5:16489. doi: 10.1038/srep16489.

18.

Association of IL-2 polymorphisms and IL-2 serum levels with susceptibility to HBV-related hepatocellular carcinoma in a Chinese Zhuang population.

Peng Q, Li H, Lao X, Deng Y, Chen Z, Qin X, Li S.

Infect Genet Evol. 2014 Oct;27:375-81. doi: 10.1016/j.meegid.2014.08.021. Epub 2014 Aug 27.

PMID:
25173083
19.

Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma.

Han YF, Zhao J, Ma LY, Yin JH, Chang WJ, Zhang HW, Cao GW.

World J Gastroenterol. 2011 Oct 14;17(38):4258-70. doi: 10.3748/wjg.v17.i38.4258. Review.

20.

The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.

Qi LN, Bai T, Chen ZS, Wu FX, Chen YY, De Xiang B, Peng T, Han ZG, Li LQ.

Liver Int. 2015 Mar;35(3):999-1009. doi: 10.1111/liv.12460. Epub 2014 Jan 27.

PMID:
24461059

Supplemental Content

Support Center